Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 16 03 2020
accepted: 18 05 2020
pubmed: 24 8 2020
medline: 15 12 2020
entrez: 24 8 2020
Statut: ppublish

Résumé

Chronic non-bacterial osteomyelitis (CNO) is a rare non-infectious bone inflammatory disorder; when multifocal, it is referred to as Chronic Recurrent Multifocal Osteomyelitis (CRMO). This study evaluates the demographic, clinical and radiological characteristics of a multi-centre cohort of patients with CNO/CRMO. Demographic and clinical data of patients with an established diagnosis of CNO/CRMO followed at paediatric rheumatology centres across Europe (Italy, France, Slovenia) and India were retrospectively collected. There were no demographic differences across countries, but time to diagnosis was significantly longer in India (p=0.041). Pain was almost invariably present at disease onset; functional impairment was more frequent among Italian and Slovenian patients (p=0.001). The number of sites of bone involvement was similar between genders and countries, with long bone metaphises being the most common site. Raised acute phase reactants, detected in >50% of patients, were not associated with clinical manifestations or response to treatment. Comorbidities, evinced in 37% of patients, were equally distributed between genders and nationalities. Imaging approach was similar across countries, without any association between radiological findings and clinical manifestations. NSAIDs were almost invariably used as first-line treatment, but response rate was significantly lower in Italy (p=0.02). Methotrexate was used in 28% of case, with an overall rate of response of 82%. Health conditions and rate of permanent deformities were similar across different countries. The differences in clinical presentation, radiological features and response to treatment described in this multinational cohort of CNO/CRMO might provide novel insights into this still elusive disease.

Identifiants

pubmed: 32828142
pii: 15494

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1255-1262

Auteurs

Lisa Gamalero (L)

University of Udine, Italy.

Alexandre Belot (A)

Paediatric Rheumatology, Nephrology, Dermatology Unit, National Reference Centre for Rheumatism and Systemic Autoimmune Diseases in Children RAISE, Hospices Civils de Lyon, France.

Mojca Zajc Avramovic (M)

Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Slovenia.

Teresa Giani (T)

Rheumatology Unit, Azienda Ospedaliero Universitaria Meyer, Florence, and University of Siena, Italy.

Giovanni Filocamo (G)

Paediatric Rheumatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Sandesh Guleria (S)

Paediatric Allergy Immunology Unit, Advanced Paediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Giovanna Ferrara (G)

Santa Maria Annunziata Hospital, ASL Toscana Centro, Florence, Italy.

Francesca Minoia (F)

Paediatric Rheumatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Michael Hofer (M)

Paediatric Unit, Centre Multisite Romand de Rhumatologie Pediatrique/Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Jean Paul Larbre (JP)

Rheumatology Unit, Hopital Lyon Sud, Lyon, France.

Melanie Aureal (M)

Rheumatology Unit, Hopital Lyon Sud, Lyon, France.

Natasa Toplak (N)

Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Slovenia.

Tadej Avcin (T)

Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Slovenia.

Cecilia Beatrice Chighizola (CB)

Experimental Laboratory of Immunological and Rheumatologic Researches, Immunology and Rheumatology Unit, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy. c.chighizola@auxologico.it.

Rolando Cimaz (R)

Department of Clinical Sciences and Community Health, University of Milan, and Paediatric Rheumatology Unit, ASST G. Pini & CTO, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH